Kempf, K.; Röhling, M.; Niedermeier, K.; Gärtner, B.; Martin, S.
Individualized Meal Replacement Therapy Improves Clinically Relevant Long-Term Glycemic Control in Poorly Controlled Type 2 Diabetes Patients. Nutrients 2018, 10, 1022.
https://doi.org/10.3390/nu10081022
AMA Style
Kempf K, Röhling M, Niedermeier K, Gärtner B, Martin S.
Individualized Meal Replacement Therapy Improves Clinically Relevant Long-Term Glycemic Control in Poorly Controlled Type 2 Diabetes Patients. Nutrients. 2018; 10(8):1022.
https://doi.org/10.3390/nu10081022
Chicago/Turabian Style
Kempf, Kerstin, Martin Röhling, Katja Niedermeier, Babette Gärtner, and Stephan Martin.
2018. "Individualized Meal Replacement Therapy Improves Clinically Relevant Long-Term Glycemic Control in Poorly Controlled Type 2 Diabetes Patients" Nutrients 10, no. 8: 1022.
https://doi.org/10.3390/nu10081022
APA Style
Kempf, K., Röhling, M., Niedermeier, K., Gärtner, B., & Martin, S.
(2018). Individualized Meal Replacement Therapy Improves Clinically Relevant Long-Term Glycemic Control in Poorly Controlled Type 2 Diabetes Patients. Nutrients, 10(8), 1022.
https://doi.org/10.3390/nu10081022